Objectives-Immune recognition of the major structural proteins of rubella virus by peripheral blood mononuclear cells and synovial inflammatory infiltrates of a patient with documented chronic rubella associated arthritis was compared with responses of normal healthy rubella virus immunoreactive subjects to establish if there were unusual response patterns associated with rubella associated arthritis in this subject. Methods-Synthetic peptides (16-33 amino acids in length) representing selected amino acid sequences of the rubella virus envelope (El and E2) and capsid (C) proteins were used in lymphocyte stimulation assays with peripheral blood mononuclear cells or synovial inflammatory infiltrates to determine T lymphocyte recognition of antigenic sites within the synthetic peptides. A rubella virus specific polymerase chain reaction was used to determine the persistence of rubella virus in the patient's cells. Results-The patient's peripheral blood mononuclear cells showed abnormally increased lymphoproliferative responses to three El synthetic peptides encompassing residues 219-234, 389-411, and 462-481, and one E2 synthetic peptide containing the sequence 50-72, of which the last three were predicted to contain T cell antigenic sites. Although the patient's peripheral blood mononuclear cells showed positive proliferative responses to C synthetic peptides, these were not unusual. The number of synthetic peptides within the El, E2, and C panels recognised by the patient's peripheral blood mononuclear cells was greater than was previously observed in normal healthy subjects. The recognition of synthetic peptides by synovial inflammatory infiltrates was similar to peripheral blood mononuclear cells but the responses measured were lower. The polymerase chain reaction was negative for rubella virus detection in peripheral blood mononuclear cells and synovial inflammatory infiltrates.
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Conclusions-Abnormally increased T cell recognition of antigenic sites within rubella virus El and E2 proteins observed in this patient with rubella associated arthritis suggests chronic antigenaemia due to persistent rubella virus in tissue sites other than peripheral blood mononuclear cells or synovial inflammatory infiltrates.
(Ann Rheum Dis 1993; 52: 590-594)
The association of rubella virus with the development of joint manifestations (arthritis or arthralgia, or both) after natural infection or vaccination, particularly in adult women, has long been recognised.' Rubella associated arthropathy is thought to be due to an underlying defect in the protective immune response leading to the persistence of the rubella virus in tissue sites such as the synovium with either immunologically or virally mediated tissue damage. The isolation of rubella virus from peripheral blood mononuclear cells or synovial inflammatory cells from some adult patients with rubella associated arthritis2 supports this hypothesis. It remains unclear, however, if there are specific immunological defects associated with rubella associated arthritis.
Reports of low levels of antibody reactive with a synthetic peptide representing a newly defined neutralisation domain. of the rubella virus El envelope protein' suggest that patients with congenital rubella syndrome, those in whom rubella virus immunisation failed, and certain patients with rubella associated arthritis may have specific defects in immune recognition. It is still unclear whether the antibody is the sole protective mechanism in rubella and T lymphocyte responses have been measured in human cells stimulated with whole rubella virus4 or synthetic peptides representing defined amino acid sequences of the rubella virus envelope (El, E2) and capsid (C) proteins.5 This paper reports the case of an adult woman with chronic rubella associated arthritis who has been the subject of two previous papers.2 8 1, E2) showed positive responses of peripheral blood mononuclear cells to seven of 10 synthetic peptides tested. One sequence represented in peptide E2-6(50-72) induced a particularly strong response which was seven fold higher than the highest stimulation index observed with this synthetic peptide in normal subjects. Similar response patterns to E2 synthetic peptides were observed in synovial inflammatory infiltrate studies (fig 2, E2) with the exception of peptide E2-4(35-58V), which induced proliferation of synovial inflammatory infiltrates but not peripheral blood mononuclear cells.
C Peptide studies (table; fig 1, C) also showed a high frequency of recognition (5/8) of these sequences by the patient's peripheral blood mononuclear cells; however, the stimulation indices measured were similar to those observed with normal cells. Only three synthetic peptides were tested with synovial inflammatory infiltrates and all showed responses comparable with peripheral blood mononuclear cells (fig 2, C) . Figures 1 and 2 and the table also show synthetic peptide responses relative to those observed when peripheral blood mononuclear cells and synovial inflammatory infiltrates were stimulated with heat inactivated whole rubella virus.
Discussion
The abnormally increased cellular immunoreactivity to rubella virus antigens observed in peripheral blood mononuclear cells and synovial inflammatory infiltrates collected in this follow up study of a patient with chronic rubella associated arthritis are consistent with previous reports of increased lymphoproliferative reactivity to whole rubella virus2 8 in this patient. Consistent observations of rubella virus specific cellular hyperreactivity suggest chronic antigenaemia or low-level persistence of rubella virus. Although rubella virus was detected by cocultivation techniques in synovial inflammatory infiltrates of this patient several years earlier,2 rubella virus genomic sequences were not detected in either peripheral blood mononuclear cells or synovial inflammatory infiltrates at this time, nor have they been detected by rubella virus-specific polymerase chain reaction in blood or synovial fluid samples collected on other occasions (unpublished data). Rubella virus has been detected by polymerase chain reaction amplification techniques in serial studies of peripheral blood mononuclear cells obtained from two other patients with rubella associated arthritis, however, but became undetectable after the start of immunosuppressive treatment (Mitchell L A, unpublished data). Hence, failure to detect rubella virus by polymerase chain reaction in this patient's cells at this time was not surprising. Despite the sensitivity of rubella virus polymerase chain reaction detection, however, owing to the small sample sizes used, additional amplification by coculture techniques or cell activation may be necessary to further amplify the rubella virus if it is present in relatively few cells in the populations being evaluated.
By using panels of synthetic peptides representing selected non-overlapping and overlapping sequences of rubella virus El, E2, and C proteins to stimulate the proliferation of freshly isolated peripheral blood mononuclear cells and synovial inflammatory infiltrates collected on one occasion from this patient with chronic rubella associated arthritis, we observed abnormally high levels of lymphocyte reactivity to some synthetic peptides as well as an increased frequency of recognition of synthetic peptides within each panel compared with that observed in normal healthy rubella virus immunoreactive subjects. The synthetic peptides used were originally synthesised for antibody binding studies and contain sequences predicted to be exposed on the protein surface. 3 Hence these synthetic peptides may only partially represent the antigenic repertoire of the rubella virus proteins. Analysis of rubella virus E 1, E2, and C sequences for a propensity to form amphipathic helices that have been associated with T cell antigenic sites in other proteins, '4 however, showed that several of the rubella virus synthetic peptides contained such regions (indicated with an asterisk in the table). These synthetic peptides had been evaluated in earlier studies6 7 for their relative abilities to stimulate proliferative 'responses of peripheral blood mononuclear cells of normal healthy rubella virus reactive subjects. The same studies also showed that the antigenic sites represented in these synthetic peptides were also broadly recognised across several different major histocompatibility class II genotypes. Hence these relatively large synthetic peptides may represent single immunodominant antigenic sites or clusters of T cell antigenic sites. These earlier studies also showed that the synthetic peptides were recognised by rubella virus specific T cell lines, suggesting that these sequences are likely to be representative of naturally processed rubella virus peptides.
In Observations of similar patterns of immunoreactivity of synovial inflammatory infiltrates with synthetic peptides indicate that these methods will be useful for antigenic site mapping in inflammatory cell populations. Future investigations will use cloned T cell lines prepared from peripheral blood mononuclear cell and synovial inflammatory infiltrate populations to determine the exact antigen sites lying within these immunoreactive regions of rubella virus proteins and their relative roles in the development of protective (or adverse) immunity to rubella virus.
